Publication | Closed Access

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

HypertensionGestational HypertensionPregnancy DisordersHypertensive DisordersPediatricsGynecologyObstetric HypertensionPregnancyMaternal HealthObstetricsMaternal-fetal MedicinePublic HealthMedicineHigh-risk Pregnancy